The stock of UnitedHealth Group Inc (NYSE:UNH) reached all time high today, Oct, 19 and still has $240.40 target or 66.00% above today’s $144.82 share price. This indicates more upside for the $147.45 billion company. This technical setup was reported by Barchart.com. If the $240.40 PT is reached, the company will be worth $97.32B more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 1.24M shares traded hands. UnitedHealth Group Inc (NYSE:UNH) has risen 14.80% since March 16, 2016 and is uptrending. It has outperformed by 9.26% the S&P500.
Analysts await UnitedHealth Group Inc (NYSE:UNH) to report earnings on October, 20. They expect $2.07 EPS, up 25.45% or $0.42 from last year’s $1.65 per share. UNH’s profit will be $2.11B for 17.49 P/E if the $2.07 EPS becomes a reality. After $1.96 actual EPS reported by UnitedHealth Group Inc for the previous quarter, Wall Street now forecasts 5.61% EPS growth.
UnitedHealth Group Inc (NYSE:UNH) Ratings Coverage
Out of 15 analysts covering UnitedHealth Group (NYSE:UNH), 15 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. UnitedHealth Group has been the topic of 19 analyst reports since September 2, 2015 according to StockzIntelligence Inc. The stock has “Outperform” rating given by Credit Suisse on Wednesday, December 16. The firm has “Overweight” rating by JP Morgan given on Wednesday, September 16. The rating was reinitiated by Morgan Stanley on Wednesday, September 9 with “Overweight”. The rating was maintained by FBR Capital on Thursday, November 19 with “Outperform”. The firm earned “Buy” rating on Friday, April 8 by Cleveland. As per Wednesday, July 20, the company rating was maintained by RBC Capital Markets. Citigroup initiated the shares of UNH in a report on Friday, October 2 with “Buy” rating. The rating was maintained by Mizuho on Wednesday, October 19 with “Buy”. Mizuho maintained the shares of UNH in a report on Friday, November 20 with “Buy” rating. The stock of UnitedHealth Group Inc (NYSE:UNH) earned “Strong-Buy” rating by Vetr on Wednesday, September 2.
According to Zacks Investment Research, “UnitedHealth Group Inc. offers health care coverage and related services to help people achieve improved health and well-being through all stages of life. The company’s products and services reflect a number of core capabilities, including medical information management, health benefit administration, care coordination, risk assessment and pricing, health benefit design and provider contracting. With these capabilities, it is able to provide comprehensive health care management services through organized health systems and insurance products.”
Insitutional Activity: The institutional sentiment decreased to 0.92 in Q2 2016. Its down 0.02, from 0.94 in 2016Q1. The ratio fall, as 55 funds sold all UnitedHealth Group Inc shares owned while 466 reduced positions. 94 funds bought stakes while 386 increased positions. They now own 805.88 million shares or 5.42% less from 852.02 million shares in 2016Q1.
Bank & Trust owns 2,532 shares or 0.05% of their US portfolio. Moreover, Clark Capital Mgmt Group has 1.54% invested in UnitedHealth Group Inc (NYSE:UNH) for 168,497 shares. Badgley Phelps & Bell, a Washington-based fund reported 1,456 shares. Moreover, Financial Bank Of New York Mellon Corp has 0.47% invested in UnitedHealth Group Inc (NYSE:UNH) for 10.83 million shares. Palisades Hudson Asset Mgmt L P last reported 1,912 shares in the company. Ncm Capital Gru holds 1,100 shares or 1.89% of its portfolio. Advisory Ltd last reported 4,633 shares in the company. Lowe Brockenbrough owns 43,227 shares or 1.06% of their US portfolio. Hilltop Hldgs Inc, a Texas-based fund reported 1,906 shares. Croft last reported 0.59% of its portfolio in the stock. Canada Pension Plan Invest Board accumulated 0.36% or 627,580 shares. Liberty Mutual Asset Management Inc holds 73,539 shares or 0.38% of its portfolio. Westwood Gp accumulated 0.03% or 24,985 shares. Jaffetilchin Invest Prns Ltd Liability accumulated 3,621 shares or 0.15% of the stock. Capital Impact Ltd Limited Liability Company holds 10,050 shares or 0.66% of its portfolio.
Insider Transactions: Since April 20, 2016, the stock had 0 insider buys, and 3 sales for $9.41 million net activity. BURKE RICHARD T also sold $5.41M worth of UnitedHealth Group Inc (NYSE:UNH) on Wednesday, September 7. 5,000 shares were sold by BALLARD WILLIAM C JR, worth $674,355. WILENSKY GAIL R had sold 5,500 shares worth $768,924 on Friday, June 10. $127,266 worth of shares were sold by Shine Kenneth Irwin on Wednesday, April 20.
More notable recent UnitedHealth Group Inc (NYSE:UNH) news were published by: Forbes.com which released: “UnitedHealth Group Absorbs Obamacare Losses As Optum Profits Soar” on October 18, 2016, also Wsj.com with their article: “UnitedHealth Group Earnings: What to Watch” published on October 17, 2016, Fool.com published: “Why Harley-Davidson, MakeMyTrip Limited, and UnitedHealth Group Jumped Today” on October 18, 2016. More interesting news about UnitedHealth Group Inc (NYSE:UNH) were released by: Schaeffersresearch.com and their article: “Buzz Stocks: Goldman Sachs Group Inc, UnitedHealth Group Inc, and IBM Corp.” published on October 18, 2016 as well as Bloomberg.com‘s news article titled: “UnitedHealth Accused of Gouging Customers on Prescription Drugs” with publication date: October 05, 2016.
UNH Company Profile
UnitedHealth Group Incorporated, incorporated on January 25, 1977, is a health and well-being company. The Companyâ€™s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various clients and markets. Optum is a health services business serving the health care marketplace, including payers, care providers, employers, Governments, life sciences companies and consumers. The Companyâ€™s business platforms have four divisions: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.